Elrexfio 76 mg/1.9 ml, Injektionslösung

7680686460027 CH-68646 Injektionslösung
Elrexfio 76 mg/1.9 ml, Injektionslösung
Elrexfio 76 mg/1.9 ml, Injektionslösung
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
12/02/2026
Summary of Product Characteristics
Français
12/02/2026
Summary of Product Characteristics
Italien
12/02/2026

Detailed composition

Substance Quantity Type Category
elranatamabum
76.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.012 MG Substance HBESI

Reimbursement information

Public price
CHF 5374.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2024

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
68646
Drug name
Elrexfio, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FX32
Authorization status
B
Dispensing category
A
First authorization
05/09/2023
Authorization expiration date
30/09/2027
IT Number
07.16.1.
Domain
Human medicine
Field of application
Multiples Myelom

Package details

Description (FR)
ELREXFIO sol inj 76 mg/1.9ml flac 1.9 ml
Description (DE)
ELREXFIO Inj Lös 76 mg/1.9ml Durchstf 1.9 ml
Market launch
05/09/2023
Narcotic (BTM)
No

Other package sizes (1)

ELREXFIO sol inj 44 mg/1.1ml flac 1.1 ml
1 DUR
GTIN: 7680686460010
View
Buy us a coffee Explore the data